Funding · Company
Blaze Bioscience, Inc.
Seattle, WABiotech & Pharma
Blaze Bioscience, Inc. of Seattle, WA has disclosed $25M across 1 Form D offering filed with the SEC on Oct 21, 2024.
$25M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersSeattle, WAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001532854Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →